Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Advocates often highlight the possibility for substantial therapeutic outcomes, especially in diseases where conventional therapies have proven inadequate. However, crucially important to assess the considerable financial expenditure associated with